Cullen Frost Bankers Inc. increased its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 76,617 shares of the financial services provider’s stock after purchasing an additional 1,617 shares during the period. Cullen Frost Bankers Inc.’s holdings in CME Group were worth $21,117,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the stock. Great Lakes Advisors LLC grew its stake in CME Group by 2.3% in the first quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after acquiring an additional 37 shares during the period. Beaumont Financial Advisors LLC grew its stake in CME Group by 2.0% in the second quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock valued at $538,000 after acquiring an additional 38 shares during the period. Whittier Trust Co. of Nevada Inc. grew its stake in CME Group by 0.8% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 5,021 shares of the financial services provider’s stock valued at $1,384,000 after acquiring an additional 38 shares during the period. Trifecta Capital Advisors LLC grew its stake in CME Group by 59.2% in the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 42 shares during the period. Finally, OneAscent Financial Services LLC grew its stake in CME Group by 4.0% in the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider’s stock valued at $293,000 after acquiring an additional 43 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other CME Group news, Director William R. Shepard purchased 262 shares of the stock in a transaction on Thursday, September 25th. The shares were purchased at an average price of $265.19 per share, with a total value of $69,479.78. Following the completion of the transaction, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider directly owned 9,508 shares in the company, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,043 shares of company stock worth $3,527,956 in the last three months. 0.30% of the stock is owned by corporate insiders.
CME Group Stock Performance
CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the prior year, the company posted $2.56 earnings per share. CME Group’s revenue was up 10.4% on a year-over-year basis. As a group, sell-side analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio is presently 48.40%.
Analyst Ratings Changes
A number of research analysts have issued reports on the company. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. Keefe, Bruyette & Woods boosted their target price on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday, October 13th. Barclays reduced their price objective on CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 8th. Finally, Wall Street Zen cut CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and an average price target of $283.71.
Read Our Latest Report on CME Group
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- Most Volatile Stocks, What Investors Need to Know
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- What does consumer price index measure?
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.